RTM Vital Signs
Innovative healthcare tech for proactive, evidence-based care. Real-time vital sign monitoring reduces costs and improves patient quality of life.
Founded
2014Innovative healthcare tech for proactive, evidence-based care. Real-time vital sign monitoring reduces costs and improves patient quality of life.
Founded with the mission to transform healthcare from reactive and hospital-centered to preventive and proactive, RTM Vital Signs offers innovative technology solutions for real-time vital sign monitoring. Their flagship product, RTMsense, is a wearable device that uses AI to detect and prevent respiratory failure. This approach aims to improve patient quality of life and reduce healthcare costs by providing continuous, evidence-based data patterns transmitted to a central monitoring station.
RTM Vital Signs has made significant strides in the healthcare technology sector, partnering with leading biobehavioral health researchers to develop their solutions. The company has garnered attention from notable investors and healthcare professionals who recognize the potential impact of their technology. Their achievements include successful pilot programs and positive feedback from early adopters, positioning RTM Vital Signs as a key player in the shift towards person-centered, well-being-focused healthcare.
Companies similar to RTM Vital Signs include New Vital Signs, Praesidium, Thalman Health and Respira Labs.
RTM Vital Signs was founded in 2014.
RTM Vital Signs' headquarters is located in Fort Washington, PA, US.
RTM Vital Signs' most recent funding round was for $280k (USD) in November 2020.
As of Nov 1, 2020, RTM Vital Signs has disclosed funding of $455k (USD). Undisclosed round amounts are excluded.
RTM Vital Signs has 8 employees as of Feb 5, 2024.
Respira Labs
